Cancer News and Research

Latest Cancer News and Research

The Dilemma of an Aging Society research study classifies elder people into four groups

A lot of discussion has centered on proposed legislation regarding "death panels" and end of life counseling.

20 Aug 2009

Novel microRNA plays a major role in invasive breast cancer development

Research led by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, has shown for the first time that a tiny piece of RNA appears to play a major role in the development of invasive breast cancer and identified a gene that appears to inhibit invasive breast cancer.

20 Aug 2009

Peplin completes four-week enrolment phase for REGION-Ib trial

Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.

20 Aug 2009

Scientists find another mechanism that destroys tumor cells

Cells don't like to be alone. In the early stages of tumor formation, a cell might be pushed out of its normal home environment due to excessive growth. But a cell normally responds to this homeless state by dismantling its nucleus, packing up its DNA, and offering itself to be eaten by immune system cells. Simply put, the homeless cell kills itself. This process, known as apoptosis, typically stops potential cancer cells before they have a chance to proliferate.

20 Aug 2009

Managing Myeloma educational website launches forum to encourage oncology nurses to discuss myeloma challenges

Managing Myeloma (www.ManagingMyeloma.com), an accredited educational website for multidisciplinary professionals, has launched a forum designed specifically for oncology nurses. The goal of the nursing forum is to share insight about day-to-day practice challenges in caring for patients with multiple myeloma, provide updates on clinical advances, and connect with peers.

20 Aug 2009

New strategy found to increase the efficacy of protein-based drugs

A new method for attaching a large protective polymer molecule to a protein appears to improve protein drugs significantly.

20 Aug 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

Thyroid cancer patients treated successfully using a new robot-assisted endoscopic technique

Using a novel robot-assisted endoscopic technique, a team of surgeons at Yonsei University College of Medicine in Seoul, Korea, has successfully treated 200 consecutive patients with thyroid cancer. The minimally invasive operation, which has several technical and cosmetic benefits that the traditional open operation does not offer, is described in the August issue of the Journal of the American College of Surgeons.

20 Aug 2009

Siemens' state-of-the-art high-definition PET/CT scanner installed at Long Beach PET Imaging Center

Long Beach PET Imaging Center, a leading diagnostic imaging center in the Long Beach, Calif.-area, announced today it has completed the installation of a new state-of-the-art HD (high-definition) PET/CT scanner, the first of its kind in the area.

20 Aug 2009

Study finds long-term exposure to progesterone may lead to growth of tumors

Scientists at Michigan State University have found exposure to the hormone progesterone activates genes that trigger inflammation in the mammary gland.

20 Aug 2009

Study unveils detrimental effects of high-dose ursodeoxycholic acid on patients with PSC

Primary sclerosing cholangitis (PSC) is an uncommon chronic liver disease characterized by progressive inflammation and destruction of the bile ducts. The disease progresses slowly, usually leading to biliary cirrhosis, portal hypertension and liver failure over a 10-15 year period. PSC is a common cause of adult cholestatic liver diseases and a primary source behind many of the liver transplantations in U.S. adults. At least 70% of PSC cases are associated with chronic inflammatory bowel disease (IBD), usually ulcerative colitis. Currently, there is no cure for PSC and prospective treatments remain ineffective.

20 Aug 2009

Low income women less likely to be screened for cancer in Ontario

Less than half of Ontario women with abnormal Pap tests receive recommended and potentially life-saving follow-up care, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). What's more, low-income women are less likely to be screened for cancer compared to their high-income counterparts.

20 Aug 2009

Researcher of LA BioMed elected to distinguished fellow status of SVS

Carlos E. Donayre, MD, a researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), has been elected to distinguished fellow status of the Society for Vascular Surgery- (SVS).

20 Aug 2009

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Vanderbilt University has been selected as one of 10 centers in the nation to participate in the Chemical Biology Consortium (CBC), a major new initiative to facilitate the discovery and development of new agents to treat cancer.

20 Aug 2009

Official launch of the FocusUP website announced

HST Global, Inc. today announced the official launch of the FocusUP® Website located at www.focusup.com FocusUP is the cognitive function product endorsed and recommended by Dr. Kyl Smith under a Joint Venture with Dalham, LLC (an affiliate company of The Health Network, Inc.).

20 Aug 2009

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

20 Aug 2009

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

InterMed Discovery (IMD), a world class natural product lead-discovery company, today announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.

20 Aug 2009

Scientists develop new technique to target brain cancer cells

Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

20 Aug 2009

GHX OnDemand AP software-as-a-service solution helps hospitals reduce invoicing processing costs

A growing number of healthcare providers are using the OnDemand AP(SM) solution by GHX to automate and streamline their accounts payable processes, reducing invoice processing costs and cycle time, and improving internal controls and cash flow management. With OnDemand AP, hospitals can receive 100 percent of their invoices electronically, even from suppliers who do not currently support electronic invoicing. By eliminating the need for manual data entry and accelerating invoice approval, hospitals can reduce invoicing processing costs by more than 80 percent.

20 Aug 2009

National Science Foundation funds CMU for developing revolutionary computational tools

A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.

20 Aug 2009

Cancer News and Research

Latest Cancer News and Research

The Dilemma of an Aging Society research study classifies elder people into four groups

Novel microRNA plays a major role in invasive breast cancer development

Peplin completes four-week enrolment phase for REGION-Ib trial

Scientists find another mechanism that destroys tumor cells

Managing Myeloma educational website launches forum to encourage oncology nurses to discuss myeloma challenges

New strategy found to increase the efficacy of protein-based drugs

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Thyroid cancer patients treated successfully using a new robot-assisted endoscopic technique

Siemens' state-of-the-art high-definition PET/CT scanner installed at Long Beach PET Imaging Center

Study finds long-term exposure to progesterone may lead to growth of tumors

Study unveils detrimental effects of high-dose ursodeoxycholic acid on patients with PSC

Low income women less likely to be screened for cancer in Ontario

Researcher of LA BioMed elected to distinguished fellow status of SVS

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Official launch of the FocusUP website announced

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

Scientists develop new technique to target brain cancer cells

GHX OnDemand AP software-as-a-service solution helps hospitals reduce invoicing processing costs

National Science Foundation funds CMU for developing revolutionary computational tools

Understanding the DNA Damage Response in Innate Immunity eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in